Items where authors include "Pandha, H"

Article

Samson, A orcid.org/0000-0002-3081-7850, West, EJ orcid.org/0000-0001-7449-120X, Carmichael, J et al. (27 more authors) (2022) Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients. Cancer Immunology Research, 10 (6). pp. 745-756. ISSN 2326-6066

Kottke, T, Tonne, J, Evgin, L et al. (19 more authors) (2021) Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature Communications, 12 (1). 1930. ISSN 2041-1723

Driscoll, CB, Schuelke, MR, Kottke, T et al. (17 more authors) (2020) APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy. Nature Communications, 11. 790. ISSN 2041-1723

Müller, LME, Holmes, M, Michael, JL et al. (20 more authors) (2019) Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21. Journal for ImmunoTherapy of Cancer, 7. 164. ISSN 2051-1426

Jennings, VA, Scott, GB orcid.org/0000-0003-0021-9400, Rose, AMS et al. (13 more authors) (2019) Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular Therapy, 27 (6). pp. 1139-1152. ISSN 1525-0016

Jiang, X, Finucane, HK orcid.org/0000-0003-3864-9828, Schumacher, FR orcid.org/0000-0002-3073-7463 et al. (330 more authors) (2019) Shared heritability and functional enrichment across six solid cancers. Nature Communications, 10. 431. ISSN 2041-1723

Annels, NE, Arif, M, Simpson, GR et al. (11 more authors) (2018) Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. Molecular Therapy - Oncolytics, 9. C. pp. 1-12. ISSN 2372-7705

Samson, A orcid.org/0000-0002-3081-7850, Scott, KJ orcid.org/0000-0002-5790-9579, Taggart, D et al. (36 more authors) (2018) Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science Translational Medicine, 10 (422). eaam7577. ISSN 1946-6234

Kottke, T, Evgin, L, Shim, KG et al. (12 more authors) (2017) Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer Immunology Research, 5 (11). pp. 1029-1045. ISSN 2326-6066

Ilett, E, Kottke, T, Thompson, J et al. (12 more authors) (2017) Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy. Gene Therapy, 24 (1). pp. 21-30. ISSN 0969-7128

Kottke, T, Shim, KG, Alonso-Camino, V et al. (12 more authors) (2016) Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular Therapy - Oncolytics, 3. 16030.

Gusev, A, Shi, H, Kichaev, G et al. (205 more authors) (2016) Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. NATURE COMMUNICATIONS, 7. ARTN 10979. ISSN 2041-1723

Rajani, K, Parrish, C, Kottke, T et al. (10 more authors) (2016) Combination therapy with reovirus and anti-PD-1 blockade controls tumor growth through innate and adaptive immune responses. Molecular Therapy, 24 (1). pp. 166-174. ISSN 1525-0016

Roulstone, V, Pedersen, M, Kyula, J et al. (14 more authors) (2015) BRAF- and MEK-targeted small molecule inhibitors exert enhanced antimelanoma effects in combination with oncolytic reovirus through ER stress. Molecular Therapy, 23 (5). pp. 931-942. ISSN 1525-0016

Seth, R, Khan, AA, Pencavel, TD et al. (8 more authors) (2015) Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus-Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma. Plastic and Reconstructive Surgery, 135 (2). 475 - 487. ISSN 0032-1052

Zaidi, S, Blanchard, M, Shim, K et al. (13 more authors) (2015) Mutated BRAF emerges as a major effector of recurrence in a murine melanoma model after treatment with immunomodulatory agents. Molecular Therapy, 23 (5). 845 - 856. ISSN 1525-0016

Ilett, E orcid.org/0000-0002-9875-0322, Kottke, T, Donnelly, O et al. (10 more authors) (2014) Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus. Molecular Therapy, 22 (10). pp. 1851-1863. ISSN 1525-0016

Alonso-Camino, V, Rajani, K, Kottke, T et al. (12 more authors) (2014) The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular Therapy, 22 (11). 1936 - 1948. ISSN 1525-0016

Bradley, S orcid.org/0000-0002-2038-2056, Jakes, A, Harrington, K et al. (3 more authors) (2014) Applications of coxsackievirus A21 in oncology. Oncolytic Virotherapy, 3. pp. 47-55. ISSN 2253-1572

Jennings, V, Ilett, EJ orcid.org/0000-0002-9875-0322, Scott, K orcid.org/0000-0002-5790-9579 et al. (10 more authors) (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International Journal of Cancer, 134 (5). pp. 1091-1101. ISSN 0020-7136

Kottke, T, Boisgerault, N, Diaz, RM et al. (12 more authors) (2013) Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature Medicine, 19. 1625 - 1631. ISSN 1078-8956

Donnelly, O, Harrington, K, Melcher, A et al. (1 more author) (2013) Live viruses to treat cancer. Journal of the Royal Society of Medicine, 106 (8). 310 - 314. ISSN 0141-0768

Boisgerault, N, Kottke, T, Pulido, J et al. (11 more authors) (2013) Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular Therapy, 21 (8). 1507 - 1516. ISSN 1525-0016

Donnelly, O, Vile, R, Pandha, H et al. (2 more authors) (2012) The hitchhiker's guide to virotherapy. Oncotarget, 3 (8). pp. 735-736. ISSN 1949-2553

Hall, K, Scott, KJ, Rose, A et al. (9 more authors) (2012) Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia. BioResearch Open Access, 1 (1). pp. 3-15. ISSN 2164-7844

Kottke, T, Errington, F orcid.org/0000-0003-2155-534X, Pulido, J et al. (12 more authors) (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine, 17 (7). pp. 854-859. ISSN 1078-8956

Steele, L, Errington, F orcid.org/0000-0003-2155-534X, Prestwich, R et al. (7 more authors) (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer, 10 (1). 20. ISSN 1476-4598

John, J, Ismail, M, Riley, C et al. (4 more authors) (2010) Differential effects of Paclitaxel on dendritic cell function. BMC Immunology, 11. 14. - . ISSN 1471-2172

Merrick, AE, Errington, F orcid.org/0000-0003-2155-534X, Milward, K et al. (8 more authors) (2005) Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming. British Journal of Cancer, 92 (8). pp. 1450-1458. ISSN 0007-0920

Proceedings Paper

Kottke, T, Shim, KG, Evgin, L et al. (13 more authors) (2016) Immunogenicity of Self Tumor Associated Antigens Is Enhanced Through Protein Truncation. In: Molecular Therapy. 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 04-07 May 2016, Washington DC, USA. Nature Publishing Group , S28-S28.

Alonso-Camino, V, Rajani, K, Kottke, T et al. (11 more authors) (2014) The Profile of Tumor Antigens Which Can Be Targeted By Immunotherapy Depends Upon the Tumor's Anatomical Site. In: Molecular Therapy. 7th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), 21-24 May 2014, Washington, DC, USA. Nature Publishing Group , S200-S200.